C12Y 304/17021
Glutamate carboxypeptidase ii
Official title: Glutamate carboxypeptidase II (3.4.17.21)
C12Y304/17021 (Glutamate carboxypeptidase ii) appears on 43 US grants and 64 published applications in this corpus.
Search patents in C12Y- Granted patents
- 43
- Published applications
- 64
- Assignees
- 27
- Inventors
- 116
- Latest grant
- 25 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 4 |
| 2014 | 1 | 1 |
| 2015 | 4 | 5 |
| 2016 | 2 | 8 |
| 2017 | 6 | 10 |
| 2018 | 3 | 2 |
| 2019 | 4 | 7 |
| 2020 | 6 | 8 |
| 2021 | 7 | 4 |
| 2022 | 2 | 4 |
| 2023 | 2 | 1 |
| 2024 | 4 | 2 |
| 2025 | 1 | 4 |
By publication year.
Recent patents
- PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy25 Feb 2025US 12,233,137 B1Duke University
- Site-specific conjugation of linker drugs to antibodies and resulting ADCs31 Dec 2024US 12,180,552 B2Byondis B.V.
- PSMA-based molecular-genetic reporter system1 Oct 2024US 12,104,214 B2The Johns Hopkins University
- PSMA binding ligand-linker conjugates and methods for using17 Sep 2024US 12,091,693 B2Purdue Research Foundation
- Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same14 May 2024US 11,980,659 B2Inovio Pharmaceuticals, Inc.
- Method of treating prostate cancer9 Oct 2025US 2025/0312497 A1Novartis AG
- Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy5 Jun 2025US 2025/0177580 A1Duke University
- Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The Same27 Mar 2025US 2025/0101399 A1Inovio Pharmaceuticals, Inc.
- Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy20 Feb 2025US 2025/0057996 A1Duke University
- Psma-targeted nir dyes and their uses24 Oct 2024US 2024/0350677 A1On Target Laboratories, LLC
Most cited
By later US patents
- Induced activation in dendritic cell40US 7,404,950 B2Baylor College of Medicine · 2008
- Induced activation in dendritic cells35US 8,999,949 B2Baylor College of Medicine · 2015
- PSMA binding ligand-linker conjugates and methods for using34US 9,951,324 B2Purdue Research Foundation · 2018
- Induced activation in dendritic cells33US 8,771,671 B2Baylor College of Medicine · 2014
- PSMA-targeted NIR dyes and their uses26US 9,801,956 B2On Target Laboratories, LLC · 2017